Advertisement

Digestive Diseases and Sciences

, Volume 47, Issue 2, pp 256–264 | Cite as

Hiatal Hernia and Acid Reflux Frequency Predict Presence and Length of Barrett's Esophagus

  • Benjamin Avidan
  • Amnon Sonnenberg
  • Thomas G. Schnell
  • Stephen J. Sontag
Article

Abstract

One third of the general population may experience reflux symptoms, yet only a small fraction of patients with gastroesophageal reflux disease (GERD) have Barrett's esophagus. The aim of the present study was to compare the characteristics of GERD patients with and without Barrett's esophagus and identify potential risk factors for the appearance of Barrett's esophagus in reflux disease. Outpatients from a gastroenterology clinic who underwent upper gastrointestinal endoscopy, esophageal manometry, and 24-hr pH monitoring were recruited into a case-control study. A total of 256 case subjects with endoscopically and histologically proven Barrett's esophagus were compared to a control group of 229 subjects with nonerosive reflux disease. As compared to nonerosive reflux disease, Barrett's esophagus was strongly associated with more reflux episodes. Barrett's esophagus occurred more frequently among subjects with hiatus hernia and among subjects who consumed large amounts of alcohol or cigarettes. Frequent reflux episodes, hiatus hernia, smoking, and alcohol consumption were also risk factors for an increased length of Barrett's mucosa. Total esophageal mucosal acid contact time at pH < 4 was a significant risk factor for the length but not the presence of Barrett's esophagus. Intake of aspirin or NSAIDs was similar in patients with and without Barrett's esophagus. In conclusion, in comparison with nonerosive reflux disease, Barrett's esophagus is characterized by risk factors usually indicative of severe types of GERD. Mechanisms in addition to acid reflux must contribute to the development of Barrett's esophagus.

alcohol consumption cigarette smoking epidemiology esophageal pH-monitoring gastroesophageal reflux disease hiatus hernia intestinal metaplasia lower esophageal sphincter pressure 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Spechler JS, Goyal RK: The columnar-lined esophagus, intestinal mataplasia, and Norman Barrett. Gastroenterology 110:614–621, 1996Google Scholar
  2. 2.
    Spechler JS, Goyal RK: Barrett's esophagus. N Engl J Med 315:362–371, 1986Google Scholar
  3. 3.
    Dent J, Bremner CG, Collen MJ, Haggitt RC, Spechler JS: Working party report to the World Congress of the Gastroenterology, Sidney 1990. Barrett's esophagus. J Gastroenterol Hepatol 6:1–22, 1991Google Scholar
  4. 4.
    Collen MJ, Johnson DDA: Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus. Dig Dis Sci 37:570–576, 1992Google Scholar
  5. 5.
    Kahrilas PJ: Gastroesophageal reflux disease JAMA 276:983–988, 1996Google Scholar
  6. 6.
    Cameron AJ, Lomboy CT: Barrett's esophagus: Age, prevalence, and extent of columnar epithelium. Gastroenterology 103:1241–1245, 1992Google Scholar
  7. 7.
    Attwood SEA, DeMeester TR, Bremner CG, Barlow AP, Hinder RA: Alkaline gastroesophageal reflux: Implication in the development of complication in Barrett's columnar-lined lower esophagus. Surgery 106:764–770, 1989Google Scholar
  8. 8.
    Iascone C, DeMeester TR, Little AG, Skinner DB: Barrett's esophagus, functional assessment, proposed pathogenesis and surgical therapy. Arch Surg 118:543–549, 1983Google Scholar
  9. 9.
    Mulholland MW, Ried BJ, Levin DS, Rubin CE: Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium. Dig Dis Sci 34:1329–1335, 1989Google Scholar
  10. 10.
    Hirschowitz BI: Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls. Dig Dis Sci 41:1384–1391, 1996Google Scholar
  11. 11.
    Savarino V, Sandro G, Zentilin P, Mele MR, Mansi C, Remagnino AC, Vigneri S, Malesci A, Belicchi m, lopertosa G, Celle G: Time pattern of gastric acidity in Barrett's esophagus. Dig Dis Sci 41:1379–1383, 1996Google Scholar
  12. 12.
    Gore CJ, Healey CJ, Sutten R, Eyre-Brook IA, Gear HWL, Shepherd NA, Wilkinson P: Regression of columnar lined (Barrett's) esophagus with continuous omeprazole therapy. Alimernt Pharmacol Ther 7:623–628, 1993Google Scholar
  13. 13.
    Sampliner RE: Effect of up to 3 years of high dose lansoprazole on Barrett's esophagus. Am J Gastroenterol 89:1844–1848, 1994Google Scholar
  14. 14.
    Sampliner RE, Garewal HS, Fennerthy MB, Aichin M: Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci 35:93–96, 1990Google Scholar
  15. 15.
    Sharma P, Sampliner RE, Camargo E: Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol 92:582–585, 1997Google Scholar
  16. 16.
    Peters FTM, Ganesh S, Kuipers EJ, Sluiter WJ, Klinkenberg-Knol EC, Lamers CB, Kleinbeuker JH: Endoscopic regression of Barrett's esophagus during omeprazole treatment: a randomized double blind study. Gut 45:489–494, 1999Google Scholar
  17. 17.
    Graham DY, Smith JL, Patterson DJ: Why do apparently healthy people use antacid tablets? Am J Gastroenterol 78:257–260, 1983Google Scholar
  18. 18.
    Mold JW, Reid LE, Davis AB, Allen ML, Decktor DL, Robinson M: Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol 86:965–970, 1991Google Scholar
  19. 19.
    Talley NJ, Zinsmeister AR, Sheleck CD, Melton LJ III: Dyspepsia and dyspepsia subgroups: A population based study. Gastroenterology 102:1259–1268, 1992Google Scholar
  20. 20.
    Sarr MG, Hamilton SR, Marrone GC, Cameron JL: Barrett's esophagus: Its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. Am J Gastroenterol 149:187–193, 1985Google Scholar
  21. 21.
    Winters C, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF, Johnson DA, Cruess DF, Cotelingam JD, Gurney MS, Cattau EL: Barrett's esophagus: A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 92:118–124, 1987Google Scholar
  22. 22.
    Johnson LF, DeMeester TR: Twenty-four pH monitoring of the distal esophagus: A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 62:325–332, 1974Google Scholar
  23. 23.
    Stein HJ, Siewert JR: Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management. Dysphagia 8:276–288, 1993Google Scholar
  24. 24.
    Hassall E: Barrett's esophagus: congenital or acquired? Am J Gastroenterol 88:819–824, 1993Google Scholar
  25. 25.
    Romero Y, Cameron AJ, Locke GR III, Schid DJ, Slezak JM, Branch CD, Melton LJ III: Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 113:1449–1456, 1997Google Scholar
  26. 26.
    Borrie J, Goldwater L: Columnar-cell lined esophagus: assessment of etiology and treatment. J Thotac Cardiovasc Surg 71:825–834, 1976Google Scholar
  27. 27.
    Robbins AH, Vincent ME, Saini M: Revised radiologic concepts of Barrett's esophagus. Gastrointest Radiol 3:377–381, 1978Google Scholar
  28. 28.
    Cameron AJ: Barrett's esophagus: Prevalence and size of hiatal hernia. Am J Gastroenterol 94:2054–2059, 1999Google Scholar
  29. 29.
    Kahrilas PJ, Dodds WJ, Kern HM, Arndorfer RC, Reece A: Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology 91:897–904, 1986Google Scholar
  30. 30.
    Mittal RK, Balaban DH: The esophagogastric junction. N Engl J Med 336:924–932, 1997Google Scholar
  31. 31.
    Eisen GM, Sandler RS, Murray S, Gottfried M: The relationship between gastroesophageal reflux disease and its complication with Barrett's esophagus. Am J Gastroenterol 92:27–31, 1997Google Scholar
  32. 32.
    Lieberman AD, Oehlke M, Helfand M, GORGE Consoritum: Risk factors for Barrett's esophagus in community-based practice. Am J Gastroenterol 92:1293–1297, 1997Google Scholar
  33. 33.
    Fitzgerald RC, Omary MB, Triadafilopoulos G: Dynamic effects of acid on Barrett's esophagus; an ex vivo proliferation and differentiation model. J Clin Invest 98:2120–2128, 1996Google Scholar
  34. 34.
    Champion G, Richter EJ, Vaezi FM, Singh S, Alexander R: Duodenogastroesophageal reflux: Relationship to pH and importance in Barrett's esophagus. Gastroenterology 107:747–754, 1994Google Scholar

Copyright information

© Plenum Publishing Corporation 2002

Authors and Affiliations

  • Benjamin Avidan
    • 1
  • Amnon Sonnenberg
    • 1
  • Thomas G. Schnell
    • 2
  • Stephen J. Sontag
    • 2
  1. 1.Department of Veterans Affairs Medical CenterAlbuquerqueUSA
  2. 2.Veterans Affairs HospitalHinesUSA

Personalised recommendations